Most Recent
Deloitte Touche Tohmatsu is facing claims by the lead applicants in two class actions against failed retail giant Dick Smith alleging its poor accounting practices contributed to the retailer's collapse.
The founder of JustKapital is considering adding Corrs Chambers Westgarth to a lawsuit he brought seeking nearly $1 million allegedly owed as part of a deal he made to step down as managing director from the litigation funder.
An appeals court has overturned a ruling awarding $2 million in compensation to United Petroleum after the state government compulsorily acquired land on which the petrol retailer operated a service station and restaurant.
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.
AFT Pharmaceuticals has agreed to a court order temporarily restraining it from distributing point of sale material containing updated claims that its painkiller Maxigesic is more effective than other over-the-counter medications.
GetSwift has warned it may seek an injunction blocking Johnson Winter & Slattery from acting as instructing lawyers to the corporate cop in its enforcement action against the logistics company, saying the firm provided advisory work for it last year.
Danish pharmaceutical giant Lundbeck secured $51.7 million in settlements to end infringement litigation with three generic makers over its patent for the top-selling Lexapro, the company has revealed.
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly "inconsistent" pleadings.
AFT Pharmaceuticals has filed a lawsuit seeking to pre-empt competitor Reckitt Benckiser from pursuing a lawsuit against it over recent ads for its painkiller Maxigesic.
A judge has denied law firm Piper Alderman's request to replace an uncooperative expert witness in a class action against KPMG over a failed takeover offer, three weeks before the matter goes to trial.